Recent worldwide outbreaks of enterovirus (EV71) have caused major epidemics of hand, foot, 53 and mouth disease (HFMD) with severe neurological complications, including acute flaccid 54 paralysis. EV71 is transmitted by the enteral route, but very little is known about the mechanisms 55 it utilizes to cross the human gastrointestinal (GI) tract. Using primary human intestinal epithelial 56 monolayers, we show that EV71 infects the GI epithelium from the apical surface, where it 57 preferentially infects goblet cells. Unlike echovirus 11 (E11), an enterovirus that infects 58 enterocytes, EV71 infection did not alter epithelial barrier function, but did reduce the expression 59 of a goblet cell-derived mucin, suggesting it alters goblet cell function. We also show that the 60 intestinal epithelium responds to EV71 infection through the selective induction of type III IFNs, 61 which potently restrict EV71 replication. Collectively, these findings define the early events 62 associated with EV71 infections of the human intestinal epithelium and show that host IFN 63 signaling controls replication in an IFN-specific manner. 64 65 69 Enterovirus 71 (EV71) has been associated with major epidemics of hand, foot, and mouth 70 disease (HFMD) worldwide and severe neurological complications, including meningitis, 71 encephalitis, and acute flaccid paralysis 1 . First identified in 1969 2 , EV71 outbreaks have occurred 72 throughout the globe, with epidemics most commonly occurring in the Asia-Pacific region. 73 Between 2008-2012, outbreaks of EV71 in China have been associated with over 7,000,000 74 cases of HFMD and almost 2500 deaths 3 . The pediatric population is at greatest risk for 75 developing EV71-associated complications, with the vast majority of fatalities occurring in children 76 3
Enteroviruses are small (~30nm) single stranded RNA viruses that cause a broad 67 spectrum of illness in humans. Disease manifestations of enterovirus infections can range from 68 acute, self-limited febrile illness to meningitis, endocarditis, acute paralysis, and even death.
requires growth as enteroids in Matrigel prior to disruption and subsequent transwell plating 140 (reviewed in 21 ). We found that fetal small intestine-derived crypts plated directly on transwell 141 inserts developed into complete monolayers within 2-3 days post-plating and exhibited distinct 142 apical and basolateral domains that contained distinct intestinal cell types such as mucin-2 143 (MUC2) positive goblet cells and chromogranin A (CHGA)-positive enteroendocrine cells at the 144 same ratio as crypts cultured in Matrigel (Figure 1A, Supplemental Figure 1C ). Using RNASeq 145 and RT-qPCR, we found that crypts plated directly in transwell inserts exhibited similar 146 transcriptional profiles (Supplemental Figure 1D ) and expression of markers of enterocytes 147 (Sucrase-isomaltase (SI), Alkaline Phosphatase (ALPL), goblet cells (MUC2, MUC5AC, MUC13, 148 MUC17), enteroendocrine cells (CHGA), Paneth cells (REG3A), and stem cells (OLFM4), 149 although we did observe significantly lower expression of LGR5 (Figure 1B, 1C) . In addition to 150 developing a multicellular phenotype, crypt monolayers (hereafter referred to as human intestinal 151 epithelium (HIE)) formed junctional complexes composed of both tight junctions (ZO-1) and 152 adherens junctions (E-cadherin) and exhibited intact barrier function as assessed by high (> 153 approximately 1000 W) transepithelial resistance (TER) values (Figure 1D, 1E) . . (B) , Hierarchical clustering heat map of differential gene expression 164 profiles (based on log2 (RPKM) values) between two independent preparations of Caco-2 cells 165 and three matched independent human enteroid cultures plated in Matrigel (MG) or T-clear 166 transwell inserts (TC) by RNAseq. Key at top (grey indicates no reads mapped). (C), for the indicated markers (alkaline phosphatase (ALPL), sucrase-isomaltase (SI), chromogranin 168 A (CHGA), mucin-2 (MUC2), regenerating islet-derived protein 3 (REG3A), and leucine-rich 169 repeat-containing G-protein coupled receptor 5 (LGR5) in three matched independent human 170 enteroid cultures plated in Matrigel or T-clear transwell inserts. Data It is unknown whether enteroviruses exhibit a preferential polarity of binding or infection in primary 182 HIE. To address this, we performed binding and infection assays from either the apical or 183 basolateral surfaces in primary HIE. These studies revealed significant differences in the capacity 184 of E11 and EV71 to bind and infect in a polarized manner. Whereas E11 exhibited an enhanced 185 capacity to infect from the basolateral surface as assessed by the production of vRNA by qPCR at 24hrs post-infection (p.i.), EV71 exhibited a much stronger preference for apical infection 187 (Figure 2A) . Consistent with this, we found that EV71 preferentially binds to the apical surface of 188 HIE as assessed by a qPCR-based binding assay ( Figure 2B) . To determine whether E11 and 189 EV71 exhibit a polarity of release, we infected HIE with EV71 or E11 from the apical or basolateral 190 surfaces, respectively, and titrated released progeny viral particles from medium isolated from the 191 apical or basolateral compartments. These studies revealed that E11 was released from both the 192 apical and basolateral compartments, although its release was skewed towards the basolateral 193 compartment ( Figure 2C) . In contrast, EV71 was solely released from the apical compartment 194 and no viral particles were detectable in the basolateral compartment ( Figure 2C) . 195 We next performed growth curves from HIEs infected with EV71 from either the apical or 196 basolateral surfaces. For these studies, we utilized neutral red (NR)-containing EV71 particles to 197 distinguish between EV71 particles that remained attached to the cell surface from those that 198 were actively replicating. This technique involves labeling of vRNA with NR, a compound that 199 crosslinks the vRNA if exposed to light 22, 23 , thus generating viral particles that are rendered non-200 infectious when exposed to light. To perform growth curves, NR-EV71 was pre-adsorbed to cells 201 from the apical or basolateral surfaces under semi-dark conditions and exposed to light 202 immediately post-binding (0hr) or following viral entry and genome release (6hr p.i.) and then 203 infected for an additional 24-96hr. NR-EV71 particles that remained at the cell surface would thus 204 be rendered non-infectious at the 6hr light exposure. Using HIEs prepared from three independent 205 human tissues and infected as described, we found that EV71 vRNA production peaked by ~24h 206 p.i. and then was rapidly reduced by 48-72h p.i., with levels diminishing significantly by 96h p.i.
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( Figure 2D ). This trend was specific for apical infection as only a single preparation exhibited any 208 detectable vRNA when infection was initiated from the basolateral surface ( Figure 2D) . In parallel, 209 we collected cell supernatants from the apical or basolateral compartments and measured 210 infectious particle release over a 24-96h period. Consistent with our vRNA data, we found that 211 the levels of infectious EV71 release were highest at 24h p.i., with levels diminishing between 48-212 96h p.i. (Figure 2E ). Of note, even when low levels of infectious EV71 particles were released 213 following infection of the basolateral surface, this release was only detectable in the apical 214 compartment (Figure 2E) . Taken together, these data show that EV71 exhibits a strong 215 preference to infect HIEs from the apical surface and that infectious particles also exhibit an apical 216 polarity of release. was pre-adsorbed to the apical or basolateral surfaces for 1hr in the semi-dark, exposed to light 229 at 0hr or at 6hr p.i., and then infection allowed to proceed for indicated hr (24-96hr). Infection was 230 assessed by production of vRNA by RT-qPCR (D) or viral titration (E) from the apical or 231 basolateral (orange) compartments. Note that in (E), no virus was detected in medium isolated 232 from the basolateral compartment. Data are from three independent preparations (ENT-1-3, in 233 grey). Average is shown in red. In (A-C) data are shown as mean ± standard deviation (**P<0.01, 234 ***P<0.001). 237 We showed previously that E11 infection of human enteroids grown in Matrigel induced significant 263 Because we observed differences in the impact of E11 and EV71 infections on epithelial barrier 264 function, we next determined whether these viruses exhibited differences in the specific cell types 265 infected in HIE. We showed previously that E11 preferentially infects enterocytes and can also 266 infect enteroendocrine cells, but is unable to infect goblet cells 20 . To determine if EV71 also 267 exhibits a cell type specificity, we first performed immunofluorescence microscopy for double- by image analysis. Data were generated from three independent HIE preparations. (E), 304 Immunofluorescence microscopy for SCARB2 (green) and MUC2 (red) from HIE grown for 7 305 days. (F), MUC2 expression as assessed by RT-qPCR at the indicated times post-infection (from 306 the apical surface). with neutral-red labeled EV71 exposed to light immediately post-adsorption 307 (0hr) or at 6hr p.i., and then infection allowed to proceed for the indicated time (in hrs). Data are 308 shown as a fold change from HIE exposed to light at 0hr and are from four independent HIE 309 preparations. In (C, D) , data are shown as mean ± standard deviation (**P<0.01, ***P<0.001).
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EV71 infection of HIE does not alter epithelial barrier function
EV71 infects goblet cells
311
Type III interferons control EV71 infection of HIE 312 Our EV71 growth curve studies revealed that the peak of EV71 replication was at 24h p.i., with 313 levels of infection declining after this time point (Figure 2D, 2E) . These data suggest that the host 314 innate immune response to EV71 might suppress viral replication at an early stage in order to 315 control its replication. To determine if this is the case, we performed RT-qPCR analyses for two 316 interferon stimulated genes (ISGs), that we previously showed were induced in HIE in response 317 to E11 infection 20 , in HIE infected with EV71. These studies showed that these ISGs, CXCL10 318 and IFI44L, were induced by EV71 infection of HIE at 24h p.i., with induction diminishing by 48h-319 72h p.i. (Figure 5A) . We next determine whether type I and/or type III IFNs were responsible for 320 this induction of ISGs by performing Luminex singleplex assays for IFNb, IFNl-1 or, IFNl-2/3 (the 321 high degree of sequence homology between these IFNs make them indistinguishable in this 322 assay). We found that EV71 infection of HIE led to the specific induction of type III IFNs, 323 specifically IFNl-2/3, at both 24h and 48h p.i., with no detectable IFN-l1 induced and very low 324 levels of IFN-b induced at 24h (Figure 5B ). Of note, IFNs were present in media collected from 325 the apical chamber following infection and we were unable to detect any IFNs from media 326 collected from the basolateral chamber. Likewise, E11 infection also induced the preferential 327 secretion of type III IFNs, but unlike EV71, but low levels of IFN-l1 were also produced in 328 response to infection (Supplemental Figure 2) . These data suggest that type III IFNs, specifically 329 IFN-l2/3, are induced in response to EV71 infection of HIE. 330 Next, we determined whether HIE exhibited differences in their ability to respond to 331 exogenous type I and III IFNs and whether these IFNs induced ISGs with differing kinetics, as 332 has been shown in adult enteroids at early time points of exposure 25 . To do this, we first performed 333 RNASeq transcriptional profiling from HIEs treated with recombinant IFN-b or IFN-l for 24h.
Differential expression analysis revealed that fetal-derived HIE potently respond to l and induce the expression of canonical ISGs to similar levels (Figure 5C, 5D, 5E) . Moreover, 336 differential expression analysis between IFN-b and IFN-l treated HIE showed that only five 337 transcripts were differentially regulated by IFN-b, and four of these transcripts were 338 downregulated in response to treatment (Figure 5F) . A kinetic profiling of the responsiveness of 339 HIE to recombinant IFN-b and IFN-l confirmed these findings and showed that there were no 340 significant differences in the kinetics by which fetal HIE respond to type I or III IFN treatment 341 (Supplemental Figure 3) . 342 Finally, we determined whether E11 and EV71 were differentially controlled by type I or III 343 IFN treatment in a virus-or IFN-specific manner. HIE were pre-treated with recombinant IFN-b or 344 IFN-l for 24h and then infected with E11 or EV71 from the basolateral or apical surfaces, 345 respectively. We found that whereas E11 was more potently restricted by IFN-b treatment as 346 detected by RT-qPCR for vRNA and viral titration, EV71 was more potently restricted by IFN-l 347 treatment (Figure 5G, 5H) . Altogether, these data show that HIE specifically induce type III IFNs The events associated with EV71 infection of the human GI tract are largely unknown. Here we 378 show that EV71 preferentially infects HIE from the apical surface where it preferentially replicates 379 in MUC2-positive goblet cells. We also show that unlike E11, an enterovirus that targets 380 enterocytes, EV71 infection of HIE has no impact on epithelial barrier function or cytoskeletal 381 morphology, but infection reduces the expression of MUC2, suggesting that its replication may 382 alter some aspect of goblet cell function. We further show that EV71 infection of HIE induces the 383 type III IFNs IFN-l2/3, which likely serve to limit EV71 replication. Collectively, these findings 384 provide important insights into the mechanisms by which EV71 and other enteroviruses bypass 385 the GI barrier and point to an important role for type III IFNs in the host response to enterovirus 386 infections within the GI tract. 387 Our data indicate that enteroviruses exhibit a distinct cell-type specificity by which they 388 infect the human GI tract in a virus-specific manner. Whereas E11 specifically targets enterocytes 389 and also infects enteroendocrine cells 20 , EV71 preferentially infects goblet cells. Although it is 390 possible that EV71 also replicates in other cell types present in HIE at levels that are below the 391 limit of detection of our assays, our data clearly point to an enrichment of EV71 replication in 392 goblet cells. The mechanistic basis for the differential cell type specificity between E11 and EV71 393 remains unclear, although the cell-type specific expression and localization of viral receptors is 394 likely to play a key role. Although the receptor for E11 is unknown, all EV71 isolates tested to date 395 utilize SCARB2 as a primary receptor 12, 26 . SCARB2, also known as lysosomal integral membrane 396 protein II (LIMPII), is an integral membrane protein that specifically localizes to lysosomes and 397 secretory granules 27 . Indeed, we found that SCARB2 was highly expressed in goblet cells, where 398 it localized to intracellular vesicles. Goblet cells are characterized by the presence of large 399 secretory vesicles that function to transport mucus to the apical surface of the epithelium. The 400 targeting of goblet cells by EV71 for intestinal infection is therefore likely driven at least in part by 401 the enrichment of SCARB2 to secretory vesicles within these cells, which might expose the 402 receptor through apical mucus release. It is also possible that EV71 utilizes other apically-403 localized attachment factors for its initial binding to the epithelial surface, much like CVB relies on 404 decay accelerating factor (DAF) to attach to the apical surface 28 , before it reaches SCARB2. EV71 405 has been shown to interact with sialic acid-linked glycans, which might facilitate its initial 406 attachment to the apical surface of the epithelium 29 . However, this binding is unlikely to be a 407 primary determinant for goblet cell infection. The cell-type specific nature of enterovirus infections 408 also suggests that the host response to infection may differ depending on the specific cell types 409 targeted by a given virus. In support of this, our data also point to important differences in the 410 impact of E11 and EV71 infection of epithelial structure and barrier function, which could 411 dramatically impact viral pathogenesis in a virus-specific manner. 412 Our findings implicate type III IFNs as key contributors in the control of enterovirus 413 infections in the GI tract. These findings are consistent with the work of others who have shown 414 that human rotaviruses 30-33 , reoviruses 34 , and noroviruses 34-36 are also controlled by intestinal-415 derived type III IFNs. However, unlike other enteric viruses such as rotavirus, which controls the 416 production of type III IFNs during infection through viral antagonism 30 , our findings show that E11 417 and EV71 infection induce the secretion of type III IFNs at the protein level, suggesting that 418 enteroviruses may lack this mechanism or be less proficient at suppressing this pathway. In cell 419 lines, even those of intestinal lineages, EV71 and other enteroviruses potently antagonize the 420 host innate immune response 37 . This suggests that mechanisms of evasion may differ in primary 421 cells, particularly those isolated from the GI tract. Our data also show that EV71, but not E11, is 422 more potently restricted by type III IFNs than type I IFNs. Similar to E11, rotaviruses are also more 423 sensitive to exogenous treatment with type I IFNs 30 . The mechanistic basis for these differences 424 in sensitivity are unclear, but our data suggest that at least in the fetal GI tract, these differences 425 are unlikely to be the result of differences in the magnitude or kinetics of ISG induction between 426 type I and III IFNs. Instead, these differences may result from differences in the cell type specific 427 nature of enteric virus infections, with rotaviruses 38 and E11 20 preferentially infecting enterocytes 428 whereas EV71 targets goblet cells. Dissecting the role of IFNs in the unique cell types of the HIE 429 will likely provide important clues into the differential role that type I and III IFNs might play in the 430 GI tract. 431 Our studies suggest that enteroviruses have evolved diverse mechanisms to infect distinct 432 cell types in the GI epithelium, which likely impacts many aspects of their pathogenesis, including 433 the role that type III IFNs play in restricting infection and spread. Defining the events associated 434 with EV71 infection in the GI tract could lead to the identification of novel therapeutic targets 435 and/or strategies to prevent or treat the pathogenesis and morbidity associated with infections by 436 this virus. Experiments were performed with EV-71 (1095), or E11 (Gregory) that were expanded as 459 described previously 41 . In some cases, experiments were performed with light-sensitive neutral-460 red viral particles, which was generated as described previously 24 . Briefly, EV71 was propagated 461 in the presence of 10µg/mL of neutral red in the semi-dark and was subsequently purified in semi-462 dark conditions by ultracentrifugation over a sucrose cushion, as described 41 . 463 For infections, wells were infected with 10^6 PFU of the indicated virus. Virus was pre-464 adsorbed to the apical or basolateral surfaces for 1hr at room temperature (basolateral infections 465 were initiated by inverting the transwell inserts). Infections were then initiated by shifting to 37 o C 466 and allowed to proceed for the times indicated. For neutral red virus experiments, particles were 467 exposed to light (on a light box) for 20min at 6h p.i. and then infected for the indicated number of 468 hours post-light exposure. In some cases, cells were exposed immediately following adsorption 469 (0hr), which served as a control. E11 and EV71 plaque assays were performed in HeLa cells 470 overlayed with 1.0% or 0.8% agarose respectively; plaques were enumerated following crystal 471 violet staining. 472 Binding assays were performed by pre-adsorbing 10^6 PFU of the indicated virus to the 473 apical or basolateral surfaces for 60min at room temperature followed by extensive washing with 474 1x PBS. Following washing, RNA was isolated immediately, and RT-qPCR performed, as 475 described below. 476 477 qPCR and cDNA synthesis 478 Total RNA was prepared from HIE using the Sigma GenElute total mammalian RNA miniprep kit, 479 according to the protocol of the manufacturer and using the supplementary Sigma DNase digest 480 reagent. RNA was reverse transcribed with the iScript cDNA synthesis kit (Bio-Rad), following the 481 manufacturer's instructions. 1 μg of total RNA was reversed transcribed in a 20 μL reaction, and 482 subsequently diluted to 100 μL for use. RT-qPCR was performed using the iQ SYBR Green 483 Supermix or iTaq Universal SYBR Green Supermix (Bio-Rad) on a CFX96 Touch Real-Time PCR 484 Detection System (Bio-Rad). Gene expression was determined based on a ΔCQ method, 485 normalized to human actin. Primer sequences can be found in Supplemental Table 1 . Figure 1. (A) , Confocal micrograph of enteroid grown in Matrigel for 7 days and immunostained for ZO-1 (in green). DAPI-stained nuclei are shown in blue. At middle, xzy and xyz cross-sections are shown at top and right. At right, maximum projection is shown. (B) , Schematic of the isolation and culturing of isolated crypts in Matrigel or on Transwells. (C), Quantification of the numbers of MUC2 and CHGA positive cells from crypts isolated and grown in Matrigel (MG) or on Transwell inserts (T-well) (normalized to DAPI). Data are shown as mean ± standard deviation and were calculated from three independent preparations. (D), MA plot generated in R following DeSeq2 analysis demonstrating the differential expression of transcripts between crypts cultured in Matrigel or on Transwell inserts. Data are plotted as log2 fold changes (y-axis) and mean expression (x-axis). Grey denotes transcripts not differentially expressed ( p<0.05). 
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